MedTrace Logo

A Clinical Study to Evaluate the Efficacy and Safety of Hemocoagulase Injection

NCT03270735 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2017-09-01

No results posted yet for this study

Summary

This is a multi-centre, randomised, double blind, placebo controlled clinical study which is designed to evaluate the efficacy and safety of hemocoagulase in the treatment of moderate to severe hemoptysis.

Conditions

  • Hemoptysis

Interventions

DRUG

Snake venom thrombin (Treatment)

Snake venom thrombin

DRUG

Placebo

No snake venom thrombin

Sponsors & Collaborators

  • Zhaoke Pharmaceutical (Hefei) Company Limited

    collaborator INDUSTRY

  • Lee's Pharmaceutical Limited

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-06
Primary Completion
2018-06-30
Completion
2018-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03270735 on ClinicalTrials.gov